2. Signaling Pathways
  3. Immunology/Inflammation
  4. Human leukocyte immunoglobulin (Ig)-like receptors (LILR)
  5. Human leukocyte immunoglobulin (Ig)-like receptors (LILR) Inhibitor

Human leukocyte immunoglobulin (Ig)-like receptors (LILR) Inhibitor

Human leukocyte immunoglobulin (Ig)-like receptors (LILR) Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-P991727
    Zamristobart
    		Inhibitor
    Zamristobart is an anti-LILRB1 (leukocyte immunoglobulin-like receptor B1) IgG4κ type humanized antibody with immunostimulant and antineoplastic activities. The recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).